Skip to main content
Premium Trial:

Request an Annual Quote

Luminex, EMD Millipore Extend Distribution Agreement

NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Tuesday it has extended its global supply and distribution agreement with EMD Millipore.

The deal with EMD Millipore, the Life Science division of Merck KGaA, is anticipated to further the development of protein assays by EMD Millipore for Luminex's xMAP platform, the Austin, Texas-based firm said. EMD Millipore also will continue to offer all of Luminex's xMAP systems, including the Magpix, Luminex 100/200, and Flexmap 3D.

Financial and other terms of the deal were not disclosed.

"This renewal of our partnership with Luminex ensures that EMD Millipore can provide customers with a complete solution for multiplexed protein detection — encompassing assay kits, instruments, software, and services — that will support them over the years," John Sweeney, head of the life sciences business at EMD Millipore, said in a statement.

EMD Millipore recently announced the availability of its Milliplex map human stem cell pluripotency kits and Milliplex map kits for cellular metabolism. The kits run on the Luminex platform.